Weese W C, Levine B W, Kazemi H
Chest. 1975 Jan;67(1):57-60. doi: 10.1378/chest.67.1.57.
Three patients with severe progressive interstitial lung disease refractory to steroid therapy were treated with immunosuppressive drugs. Biopsy material of one showed mainly fibrosis, while that of the second showed interstitial pneumonitis as well; both patients received azathioprine. Cyclophosphamide was employed in the third patient with systemic vasculitis and massive hemoptysis. All patients had reduced lung volumes and abnormal gas exchange, which continued to worsen on high doses of steroids. In patients 1 and 2, there was long-term stabilization of lung function, while pulmonary physiologic abnormalities in the patient with vasculitis reverted to normal on five months of cyclophosphamide. Although the etiology of most forms of interstitial lung disease is unknown, several reports suggest at least a partial immunologic basis. Abatement in progression of disease in this small series would suggest that a trial of immunosuppressive drugs be considered in interstitial lung disease when steroid therapy fails.
三名对类固醇治疗无效的重度进行性间质性肺病患者接受了免疫抑制药物治疗。其中一名患者的活检材料主要显示为纤维化,另一名患者的活检材料则同时显示为间质性肺炎;这两名患者均接受了硫唑嘌呤治疗。第三名患有系统性血管炎和大量咯血的患者使用了环磷酰胺。所有患者的肺容积均减小且气体交换异常,在高剂量类固醇治疗下病情仍持续恶化。在第1和第2名患者中,肺功能长期稳定,而血管炎患者在接受五个月的环磷酰胺治疗后,肺部生理异常恢复正常。尽管大多数形式的间质性肺病病因不明,但有几份报告表明至少存在部分免疫学基础。在这个小系列中疾病进展的减轻表明,当类固醇治疗失败时,对于间质性肺病可考虑试用免疫抑制药物。